Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats

British Journal of Nutrition

Volumn 104, Issue 1, 2010, Pages 67-75

  Lo, Hui Chen ^a   Wang, Yao Horng ^b   Chiou, Hue Ying ^c   Lai, Shan Hu ^d   Yang, Yu ^e  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c ANIMAL TECHNOLOGY INSTITUTE TAIWAN   (Taiwan)

^d JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Cytokines; NO; Renal histology; TAG; Uric acid

Indexed keywords

3 NITROTYROSINE; ALLOPURINOL; CASEIN; CHOLESTEROL; CREATININE; DRINKING WATER; GAMMA INTERFERON; INSULIN; NITRIC OXIDE; OXONIC ACID; PALM OIL; SAFFLOWER OIL; SERUM ALBUMIN; SOYBEAN PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; 3-NITROTYROSINE; ALBUMINOID; DRUG DERIVATIVE; TRIACYLGLYCEROL; TYROSINE; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HYPERURICEMIA; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; MALE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RAT; UREA NITROGEN BLOOD LEVEL; WISTAR RAT; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIET; DRUG COMBINATION; DRUG EFFECT; FAT INTAKE; FIBROSIS; KIDNEY; METABOLISM; NEPHROLITHIASIS; PATHOLOGY; PROTEIN INTAKE; SOYBEAN;

CARTHAMUS TINCTORIUS; RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

ALBUMINS; ANALYSIS OF VARIANCE; ANIMALS; BLOOD UREA NITROGEN; CASEINS; CHOLESTEROL; CREATININE; DIET; DIETARY FATS; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FIBROSIS; HYPERURICEMIA; INSULIN; INTERFERON-GAMMA; KIDNEY; KIDNEY CALCULI; MALE; NEPHRITIS, INTERSTITIAL; NITRIC OXIDE; OXONIC ACID; PLANT OILS; RATS; RATS, WISTAR; SAFFLOWER OIL; SOYBEAN PROTEINS; SOYBEANS; TRANSFORMING GROWTH FACTOR BETA; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; URIC ACID;

EID: 77954672282     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510000310     Document Type: Article

References (39)

1. Chang HY, Pan WH, Yeh WT, et al. (2001) Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 28, 1640-1646.
2. Lee MS, Lin SC, Chang HY, et al. (2005) High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr 14, 285-292.
3. Huang CC, Peng MC, Tsai WC, et al. (2005) The serum uric acid and related cardiovascular risk factors in south Taiwan. Southeast Asian J Trop Med Public Health 36, 259-264.
4. Menè P & Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 25, 2085-2092.
5. Mazzali M, Hughes J, Kim YG, et al. (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38, 1101-1106.
6. Johnson RJ, Titte S, Cade JR, et al. (2005) Uric acid, evolution and primitive cultures. Semin Nephrol 25, 3-8.
7. Erdogan D, Gullu H, Caliskan M, et al. (2005) Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59, 1276-1282.
8. Kang DH & Nakagawa T (2005) Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 25, 43-49.
9. Bellinghieri G, Santoro D & Savica V (2005) Pharmacological treatment of acute and chronic hyperuricemia in kidney diseased patients. Contrib Nephrol 147, 149-160.
10. Ejaz AA, Mu W, Kang DH, et al. (2007) Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2, 16-21.
11. Nakagawa T, Mazzali M, Kang DH, et al. (2003) Hyperurice-mia causes glomerular hypertrophy in the rat. Am J Nephrol 23, 2-7.
12. Sánchez-Lozada LG, Tapia E, Santamaŕ-a J, et al. (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67, 237-247.
13. Iseki K, Ikemiya Y, Inoue T, et al. (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44, 642-650. (Pubitemid 39237608)
14. Kutzing MK & Firestein BL (2008) Altered uric acid levels and disease states. J Pharmacol Exp Ther 324, 1-7.
15. Peixoto MR, Monego ET, Jardim PC, et al. (2001) Diet and medication in the treatment of hyperuricemia in hypertensive patients. Arq Bras Cardiol 76, 463-472.
16. Johnson RJ & Rideout BA (2004) Uric acid and diet-insights into the epidemic of cardiovascular disease. N Engl J Med 350, 1071-1073.
17. Fam AG (2002) Gout, diet, and the insulin resistance syndrome. J Rheumatol 29, 1350-1355.
18. Fair DE, Ogborn MR, Weiler HA, et al. (2004) Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats. J Nutr 134, 1504-1507.
19. Aguila MB, Pinheiro AR, Aquino JC, et al. (2005) Different edible oil beneficial effects (canola oil, fish oil, palm oil, olive oil, and soybean oil) on spontaneously hypertensive rat glomerular enlargement and glomeruli number. Prostaglandins Other Lipid Mediat 76, 74-85.
20. Bernstein AM, Treyzon L & Li Z (2007) Are high-protein, vegetable-based diets safe for kidney function? A review of the literature. J Am Diet Assoc 107, 644-650.
21. Shih W, Hines WH & Neilson EG (1988) Effects of cyclospor-ine A on the development of immune-mediated interstitial nephritis. Kidney Int 33, 1113-1118.
22. Bayorh MA, Abukhalaf IK & Ganafa AA (2005) Effect of palm oil on blood pressure, endothelial function and oxidative stress. Asia Pac J Clin Nutr 14, 325-339.
23. Cosge B, Gurbuz B & Kiralan M (2007) Oil content and fatty acid composition of some safflower (Carthamus tinctorius L.) varieties sown in spring and winter. Int J Natural Eng Sci 1, 11-15.
24. Avram Z & Krishnan E (2008) Hyperuricaemia-where nephrology meets rheumatology. Rheumatology 47, 960-964.
25. Khosla UM, Zharikov S, Finch JL, et al. (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67, 1739-1742.
26. Dalbeth N & Stamp L (2007) Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events. Semin Dial 20, 391-395.
27. Markel A (2005) Allopurinol-induced DRESS syndrome. Isr Med Assoc J 7, 656-660.
28. Ogborn MR, Nitschmann E, Weiler HA, et al. (2000) Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int 57, 159-166.
29. Tovar AR, Murgúa F, Cruz C, et al. (2002) A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 132, 2562-2569.
30. Azadbakht L, Atabak S & Esmaillzadeh A (2008) Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 31, 648-654.
31. Teixeira SR, Tappenden KA, Carson L, et al. (2004) Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134, 1874-1880.
32. Azadbakht L, Shakerhosseini R, Atabak S, et al. (2003) Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57, 1292-1294.
33. Chen ST, Yang HY, Huang HY, et al. (2006) Effects of various soya protein hydrolysates on lipid profile, blood pressure and renal function in five-sixths nephrectomized rats. Br J Nutr 96, 435-441.
34. Trujillo J, Cruz C, Tovar A, et al. (2008) Renoprotective mechanisms of soy protein intake in the obese Zucker rat. Am J Physiol Renal Physiol 295, F1574-F1582.
35. Ganafa AA, Socci RR, Eatman D, et al. (2002) Effect of palm oil on oxidative stress-induced hypertension in Sprague-Dawley rats. Am J Hypertens 15, 725-731.
36. Edem DO (2002) Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review. Plant Foods Hum Nutr 57, 319-341.
37. Leong XF, Aishah A, Nor Aini U, et al. (2008) Heated palm oil causes rise in blood pressure and cardiac changes in heart muscle in experimental rats. Arch Med Res 39, 567-572.
38. Ogborn MR, Nitschmann E, Bankovic-Calic N, et al. (2002) Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n-6/n-3 FA ratio in experimental polycystic kidney disease. Lipids 37, 1059-1065.
39. Ogborn MR, Nitschmann E, Goldberg A, et al. (2008) Dietary conjugated linoleic acid renal benefits and possible toxicity vary with isomer, dose and gender in rat polycystic kidney disease. Lipids 43, 783-791.